Cervical injection may boost success of uterine surgery
NCT ID NCT07102615
First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study tests whether injecting vasopressin into the cervix helps doctors completely remove pregnancy tissue left in the uterus after miscarriage, abortion, or delivery. About 50 women will be randomly assigned to receive either vasopressin or a placebo (saline) during a hysteroscopic procedure. The main goal is to see if vasopressin leads to more successful removals and less bleeding.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- vasopressin
- What this could lead to
- If it works, this could make surgery for retained pregnancy tissue more effective and reduce bleeding.
- What could go wrong
- This is a small early-phase trial with only 50 participants, so results may not apply widely. Vasopressin can cause side effects like changes in blood pressure or heart rate.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for RETAINED PRODUCTS OF CONCEPTION are added.
By submitting, you agree to our Terms of use
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
The OB/GYN Center
RECRUITINGGreenville, South Carolina, 29605, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.